Biotest AG
BIESF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $108 | $25 | $66 |
| Short-Term Investments | – | $12 | $13 | $0 |
| Receivables | – | $202 | $38 | $0 |
| Inventory | – | $480 | $488 | $473 |
| Other Curr. Assets | – | $9 | $141 | $29 |
| Total Curr. Assets | – | $810 | $705 | $739 |
| Property Plant & Equip (Net) | – | $571 | $574 | $575 |
| Goodwill | – | $6 | $0 | $0 |
| Intangibles | – | $11 | $16 | $15 |
| Long-Term Investments | – | -$10 | $13 | $11 |
| Tax Assets | – | $20 | $25 | $0 |
| Other NC Assets | – | $27 | $13 | $35 |
| Total NC Assets | – | $625 | $642 | $637 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $1,434 | $1,347 | $1,376 |
| Liabilities | – | – | – | – |
| Payables | – | $88 | $58 | $69 |
| Short-Term Debt | – | $6 | $0 | $195 |
| Tax Payable | – | $4 | $0 | $1 |
| Deferred Revenue | – | $0 | $0 | $20 |
| Other Curr. Liab. | – | $62 | $219 | $16 |
| Total Curr. Liab. | – | $160 | $277 | $301 |
| LT Debt | – | $592 | $0 | $430 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $1 | $1 | $0 |
| Other NC Liab. | – | $151 | $541 | $109 |
| Total NC Liab. | – | $743 | $542 | $539 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $59 | $0 | $58 |
| Total Liabilities | – | $903 | $819 | $840 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $40 | $40 | $40 |
| Retained Earnings | – | $275 | $268 | $277 |
| AOCI | – | $0 | $0 | $0 |
| Other Equity | – | $217 | $220 | $220 |
| Total Equity | – | $531 | $528 | $536 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $1,434 | $1,347 | $1,376 |
| Net Debt | $0 | $489 | -$25 | $558 |